MIR4771-2

Across TCGA pan-cancer cohorts, MIR4771-2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR4771-2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR4771-2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4771-2 is over-expressed in tumor.

BRCA, LUSC, and LUAD are the cancer types where MIR4771-2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4771-2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.239	<.001	4	view →
LUSC	All	All	+0.210	.008	4	view →
LUAD	All	All	+0.216	.008	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR4771-2–BRCA

Open the BRCA breakdown →